000 01438 a2200445 4500
005 20250512075844.0
264 0 _c19851011
008 198510s 0 0 eng d
022 _a0252-9564
024 7 _a10.1007/BF02919068
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFiorilli, M
245 0 0 _aThymopentin treatment of selective IgA deficiency.
_h[electronic resource]
260 _bSurvey of immunologic research
_c1985
300 _a129-34 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdjuvants, Immunologic
_xtherapeutic use
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aChild
650 0 4 _aDysgammaglobulinemia
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHormones
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aIgA Deficiency
650 0 4 _aImmunoglobulin A
_xbiosynthesis
650 0 4 _aMale
650 0 4 _aPeptide Fragments
_xtherapeutic use
650 0 4 _aT-Lymphocytes
_xclassification
650 0 4 _aThymopentin
650 0 4 _aThymopoietins
_xtherapeutic use
650 0 4 _aThymus Hormones
_xtherapeutic use
700 1 _aQuinti, I
700 1 _aRussi, G
700 1 _aSeminara, R
700 1 _aEnsoli, B
700 1 _aAiuti, F
773 0 _tSurvey of immunologic research
_gvol. 4 Suppl 1
_gp. 129-34
856 4 0 _uhttps://doi.org/10.1007/BF02919068
_zAvailable from publisher's website
999 _c3903976
_d3903976